BioMarin Pharmaceutical (BMRN)
(Delayed Data from NSDQ)
$54.36 USD
-0.78 (-1.41%)
Updated Sep 19, 2025 04:00 PM ET
After-Market: $54.36 0.00 (0.00%) 7:58 PM ET
3-Hold of 5 3
B Value B Growth B Momentum A VGM
Fundamental Charts
About Price to Cash Flow
The Price to Cash Flow ratio or P/CF is price divided by its cash flow per share. It's another great way to determine whether a company is undervalued or overvalued with the denominator being cash flow. One of the reasons why some investors prefer the P/CF ratio over the P/E ratio is because the net income of the cash flow portion rightly adds depreciation and amortization back in since these are not cash expenditures. In contrast, the net income that goes into the earnings portion of the P/E ratio does not add these in, thus artificially reducing the income and skewing the P/E ratio. Like the P/E ratio, a lower number is considered better. A value under 20 is generally considered good.
BMRN 54.36 -0.78(-1.41%)
Will BMRN be a Portfolio Killer in September?
Zacks Investment Research is releasing its prediction for BMRN based on the 1-3 month trading system that more than doubles the S&P 500.
Zacks News for BMRN
Why BioMarin Pharmaceutical (BMRN) is a Top Value Stock for the Long-Term
Here's Why BioMarin Pharmaceutical (BMRN) is a Strong Growth Stock
BMRN: What are Zacks experts saying now?
Zacks Private Portfolio Services
Are Options Traders Betting on a Big Move in BioMarin Pharmaceutical Stock?
BioMarin (BMRN) Down 4.6% Since Last Earnings Report: Can It Rebound?
Here's Why BioMarin Pharmaceutical (BMRN) is a Strong Value Stock
Other News for BMRN
BMRN forms 180 Bearish Setup on September 19
Is BMRN coiling for a breakout? NR7 shows up after rising 1.42%
November 21st Options Now Available For BioMarin Pharmaceutical (BMRN)
Is BMRN signaling a buying opportunity? Stochastic Buy Signal shows up after climbing 0.8%
Lower Bollinger Band Walk appears for BMRN after 1.51% move